Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04799249 |
|---|---|
| Brief Title: | Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC) (PRESERVE 2) |
| First Submitted : | February 18, 2021 |
| First Submitted that Met QC Criteria : | March 11, 2021 |
| First Posted : | March 16, 2021 |
| Last Update Submitted that Met QC Criteria : | January 12, 2024 |
| Last Update Posted : | January 16, 2024 |